The combination of drugs, devices, and/or biological products creates a unique intersection of disciplines within the medical device and pharmaceutical industries. While combination products such as infusion pumps can innovate the delivery of drugs and/or biological agents, they may also pose a risk to patient safety. The storage and delivery of biologics through medical devices offers an opportunity for microbial ingress and subsequent microbial growth. To mitigate these risks, combination devices may require unique container closure designs or may incorporate antimicrobials directly within the drug or biologic.
Ingestible Pill Inventories GI Tract
Overcoming Challenges in Material Selection for 3D Printed Medical Devices
Smart Bandages Improve Chronic Wound Healing
Microneedle Patch Reverses Alopecia Hair Loss
Collaborative Robotics Automates Wearable Tech Design
Improving extruded components requires careful attention to a number of factors, including dimensional tolerance, material selection, and processing. Trelleborg’s Dan Sanchez provides detailed insights into each of these considerations to help you advance your device innovations while reducing costs and speeding time to market.
Combination Products: Cross-roads of Device and Pharmacological...
Medical and Healthcare Robotics Digital Summit
Navigating Adhesive Obstacles on the Medical Device Design Journey
UV Curing Advancements for Medical Device Manufacturing
AI's Role in Advanced Medtech Manufacturing